Related Experiment Video
Updated: Mar 9, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Clinical relevance of colorectal cancer molecular subtypes
Nuria Rodriguez-Salas1, Gema Dominguez2, Rodrigo Barderas3
1Medical Oncology Department, La Paz University Hospital, Autonoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain.
Abstract:
Colorectal cancer (CRC) is characterized by alteration of critical pathways such TP53 inactivation, BRAF, PI3CA mutations, APC inactivation, KRAS, TGF-β, CTNNB mutations, disregulation of Epithelial to mesnechymal transition (EMT) genes, WNT signaling activation, MYC amplification, and others. Differences in these molecular events results in differences in phenotypic characteristics of CRC, that have been studied and classified by different models of molecular subtypes. It could have potential applications to prognosis, but also to therapeutical approaches of the CRC patients. We review and summarized the different molecular classifications and try to clarify their clinical and therapeutical relevance.
Insights
Colorectal cancer (CRC) molecular subtypes arise from genetic alterations impacting key pathways. Understanding these subtypes is crucial for improving prognosis and developing targeted therapies for CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) exhibits diverse molecular alterations, including TP53, BRAF, PI3CA, APC, KRAS, TGF-β, CTNNB mutations, EMT gene dysregulation, WNT signaling activation, and MYC amplification.
- These molecular events contribute to distinct phenotypic characteristics and drive the heterogeneity observed in CRC.
- Existing molecular classifications aim to categorize CRC based on these underlying genetic and signaling pathway differences.
Purpose of the Study:
- To review and summarize the various molecular classifications of colorectal cancer.
- To clarify the clinical and therapeutic relevance of these different molecular subtypes.
- To provide insights into how molecular subtyping can inform prognosis and treatment strategies for CRC patients.
Main Methods:
- Comprehensive literature review of studies on colorectal cancer molecular classifications.
- Analysis of key molecular alterations and their association with CRC phenotypes.
- Synthesis of information regarding the clinical and therapeutic implications of identified subtypes.
Main Results:
- CRC is characterized by a complex interplay of genetic mutations and pathway dysregulations, leading to distinct molecular subtypes.
- These subtypes exhibit varying clinical behaviors and responses to therapies.
- Current classifications highlight the potential of molecular profiling for personalized medicine in CRC.
Conclusions:
- Molecular classification is essential for understanding CRC heterogeneity and its clinical impact.
- Identifying specific molecular subtypes can guide prognosis and the selection of targeted therapeutic approaches.
- Further research into molecular subtypes will refine personalized treatment strategies for colorectal cancer.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...